Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Diasol East, Inc.
WARNING LETTER
•Diasol East, Inc.•March 17, 2017

Diasol East, Inc. – FDA Warning Letter, Mar 17, 2017

Record Details

On July 12, 2017, the FDA issued a Warning Letter to Diasol East, Inc. following an inspection from February 21 to March 17, 2017, at their Watertown, TN facility. The inspection revealed that Diasol East, a manufacturer of liquid and powder dialysate concentrate for hemodialysis, produced adulterated devices under section 501(h) of the Act. The manufacturing processes, facilities, and controls were not in conformity with the Quality System (QS) regulation (21 CFR Part 820).

Key violations include: 1. **Production Process Control (21 CFR 820.70(a)):** Failure to adequately develop, conduct, control, and monitor production processes. Procedures for Diasol Liquid Acid Concentrate manufacturing were not followed, lacked required testing documentation, referenced processes and equipment from other sites not used in Tennessee, and contained inaccurate mixing times. 2. **Finished Device Acceptance (21 CFR 820.80(d)):** Inadequate procedures for finished device acceptance. The "Final Acceptance Inspection Batch Release Criteria and Testing" procedure lacked specifics on release responsibility and documentation, had inconsistent release criteria for sodium concentration (with 20 instances of out-of-spec results in reviewed DHRs), and did not adequately describe test methods or off-site testing. 3. **Nonconforming Product Control (

Company
Diasol East, Inc.
Inspection date
March 17, 2017
Product type
Devices
Office
Florida District Office
Person
  • Blake Bevill (Director)
View Company Profile

ID · 0099ab94-6eed-4c95-b2c4-15e872f3232a

Violation Codes9
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.70(a)21 CFR 820.80(d)21 CFR 820.90(a)21 CFR 820.100(a)21 CFR 820.2221 CFR 820.40

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Diasol East, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.